Developer docs
API playgroundTry for free, no card

Search company profiles

JADBio

Full company profile

uuid0005zss

Namestring
JADBio
Legal namestring
Gnosis DA S.A.
Websiteurl
jadbio.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

JADBio (legally Gnosis DA S.A., formerly Just Add Data Bio) is a private, bootstrapped software company founded in 2013 and headquartered in Heraklion, Crete, Greece, with a US commercial presence. The company builds an automated machine learning (AutoML) platform purpose-built for biomedical and life science data, specifically engineered to handle the low-sample, high-dimensional datasets typical in genomics, proteomics, transcriptomics, metabolomics, and clinical research. The platform automates the complete machine learning pipeline including data preprocessing, feature selection, hyperparameter tuning, and model selection, and is offered through a no-code GUI for non-expert researchers and a REST API for programmatic integration. Proprietary capabilities include compact feature selection capable of 4000x biomarker reduction without predictive quality loss, survival analysis for time-to-event modeling, and out-of-sample performance estimation with bias correction. The platform is validated through peer-reviewed publications in Nature Precision Oncology and Cell Press's Cancer Cell.

Short descriptiontext

JADBio provides a no-code AutoML platform purpose-built for biomedical and life science researchers, enabling biomarker discovery, multi-omics analysis, and survival modeling without data science expertise.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated machine learning, biomarker discovery, multi-omics analysis, predictive modeling, life sciences software
Industry4 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAABAL
AutoML & Low-Code ML Platform Operations
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/ML Platforms, MLOps & Model Lifecycle Management
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
NAICS code3 codes
  • Custom Computer Programming Services541511
  • Computer Systems Design and Related Services54151
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Analytics Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription (AutoML Platform)
TypeSubscription Recurring
Description

Cloud-based AutoML platform delivered as SaaS subscription, with tiered pricing tiers including Basic (free), and paid plans for professional and enterprise use.

jadbio.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Free Basic Plan
ModelFreemiumBilling cadenceMonthly
Notes

Free Basic plan available for users to get started with AutoML. Includes access to core platform functionality.

jadbio.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

JADBio provides an automated machine learning (AutoML) platform purpose-built for low-sample, high-dimensional biomedical and life-science data. The platform automates the full ML pipeline—data preprocessing, feature selection, hyperparameter tuning, and model selection—to enable biomarker discovery, survival analysis, and predictive modeling on multi-omics data (genomics, transcriptomics, proteomics, metabolomics, clinical data and images). It is delivered via a no-code GUI for life scientists and a REST API for developers, with availability through AWS Marketplace.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 4000x reduction in biomarkers to consider without drop in predictive quality against state-of-the-art
+3 more records
Product overview1 text field

JADBio (Just Add Data Bio) offers an automated machine learning platform specifically designed for biomedical and life science data. The product portfolio consists of two main offerings: the JADBio GUI, a no-code AutoML platform for non-expert users to perform predictive modeling and biomarker discovery through a web interface, and the JADBio API, a REST API that provides programmatic access to the same AutoML capabilities for developers integrating ML into their applications. The platform is purpose-built for multi-omics data including Genomics, Transcriptome, Metagenome, Proteome, Metabolome, and Clinical Data, and specializes in low-sample, high-dimensional datasets typical in biomedical research.

Product and service2 records
1JADBio GUI
CategoryAutoML Platform
Description

A no-code AutoML platform that enables life scientists and bioinformaticians to perform automated machine learning analysis on biomedical and multi-omics data without programming expertise. Provides point-and-click access to predictive modeling, feature selection, biomarker discovery, and survival analysis. Targeted at academic and industry researchers who need ML capabilities without dedicated data science staff.

2JADBio API
CategoryDeveloper API
Description

REST API providing programmatic access to JADBio's AutoML platform, enabling developers and data scientists to integrate automated machine learning, feature selection, predictive modeling, and survival analysis into their own applications and workflows. Designed for low-sample, high-dimensional biomedical datasets including multi-omics data.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-17
Description

Black Arrow Biotech is integrating JADBio's advanced AI technology into its proprietary peptide screening platform to accelerate peptide drug discovery. This partnership combines Black Arrow's screening capabilities with JADBio's AutoML for enhanced discovery workflows.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-05
Description

DiamiR Biosciences partnered with JADBio to utilize machine learning in assay development. DiamiR develops innovative diagnostic solutions for neurological disorders and is leveraging JADBio's AutoML platform for enhanced assay development capabilities.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

QIAGEN partners with JADBio for event presence and distribution. JADBio appears at QIAGEN's booth at industry conferences such as BioData World Congress for networking and lead generation.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Filgen is a Japanese biotechnology company and partner for distribution and research collaboration in the Japanese market.

Strategic tierCoreTypeTechnology or Integration
Description

JADBio's AutoML platform is available in the AWS Marketplace, enabling cloud-based access and procurement through AWS. The partnership leverages AWS infrastructure for platform delivery.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Enterprise AutoML platform serving multiple verticals including life sciences. Directly comparable on AutoML core capability but broader and general-purpose, lacking JADBio's deep multi-omics specialization.

TypeBroad incumbent
Description

General-purpose AutoML and MLOps platform with some healthcare/life sciences customers. Comparable as an AutoML alternative but does not match JADBio's purpose-built biomedical feature selection.

TypeBroad incumbent
Description

Hyperscaler AutoML offering with broad enterprise reach. Competes for the same AutoML-for-biomedical workloads from a general-purpose cloud platform angle, with vastly greater scale.

TypeDirect peer
Description

AI-driven drug discovery company combining ML with proprietary data and wet-lab experimentation. Comparable in applying ML to life sciences, though vertically integrated into drug programs rather than selling the ML tool itself.

TypeDirect peer
Description

AI-for-biopharma platform focused on multi-modal biomedical data and federated learning for drug discovery and diagnostics. Directly comparable on multi-omics/clinical data ML for life sciences.

TypeDirect peer
Description

AI platform for cell-level disease modeling and multi-omics data in drug discovery. Comparable as a domain-specialized ML platform serving biopharma R&D customers with multi-omics inputs.

TypeBroad incumbent
Description

Computational drug discovery platform combining physics-based modeling with ML. Comparable as a software-and-AI vendor to life sciences R&D, though anchored in molecular simulation rather than biomarker AutoML.

TypeEmerging player
Description

Scientific R&D informatics platform for life sciences with ML-augmented analysis. Comparable as a software layer for biomedical researchers, though broader in scope (ELN, LIMS, analytics).

TypeEmerging player
Description

Cloud platform for life sciences R&D with growing ML/biologics capabilities. Comparable as a research informatics platform serving biologists, with overlapping buyers though different primary use cases.

TypeEmerging player
Description

Multi-omics data platform with ML-ready pipelines for biomedical researchers. Comparable as an existing partner and as an adjacent platform serving the same multi-omics + biomarker discovery workflow.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JADBio

Biomedical Analytics Softwarejadbio.com

JADBio provides a no-code AutoML platform purpose-built for biomedical and life science researchers, enabling biomarker discovery, multi-omics analysis, and survival modeling without data science expertise.

What JADBio does

JADBio (legally Gnosis DA S.A., formerly Just Add Data Bio) is a private, bootstrapped software company founded in 2013 and headquartered in Heraklion, Crete, Greece, with a US commercial presence. The company builds an automated machine learning (AutoML) platform purpose-built for biomedical and life science data, specifically engineered to handle the low-sample, high-dimensional datasets typical in genomics, proteomics, transcriptomics, metabolomics, and clinical research. The platform automates the complete machine learning pipeline including data preprocessing, feature selection, hyperparameter tuning, and model selection, and is offered through a no-code GUI for non-expert researchers and a REST API for programmatic integration. Proprietary capabilities include compact feature selection capable of 4000x biomarker reduction without predictive quality loss, survival analysis for time-to-event modeling, and out-of-sample performance estimation with bias correction. The platform is validated through peer-reviewed publications in Nature Precision Oncology and Cell Press's Cancer Cell.

JADBio firmographics

Firmographics
Name
JADBio
Legal name
Gnosis DA S.A.
Website
https://jadbio.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
JADBio provides a no-code AutoML platform purpose-built for biomedical and life science researchers, enabling biomarker discovery, multi-omics analysis, and survival modeling without data science expertise.
Ownership category
akta.pro rank

JADBio industry classification

Industry
Product category
Biomedical Analytics Software
NAICS
Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAABAL
AutoML & Low-Code ML Platform Operations
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/ML Platforms, MLOps & Model Lifecycle Management
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)

Keywords

  • Automated machine learning
  • Biomarker discovery
  • Multi-omics analysis
  • Predictive modeling
  • Life sciences software

Where JADBio is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

JADBio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Subscription (AutoML Platform): Cloud-based AutoML platform delivered as SaaS subscription, with tiered pricing tiers including Basic (free), and paid plans for professional and enterprise use.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree Basic Plan

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

JADBio product offering

Product offering

Core offering

JADBio provides an automated machine learning (AutoML) platform purpose-built for low-sample, high-dimensional biomedical and life-science data. The platform automates the full ML pipeline—data preprocessing, feature selection, hyperparameter tuning, and model selection—to enable biomarker discovery, survival analysis, and predictive modeling on multi-omics data (genomics, transcriptomics, proteomics, metabolomics, clinical data and images). It is delivered via a no-code GUI for life scientists and a REST API for developers, with availability through AWS Marketplace.

Product overview

JADBio (Just Add Data Bio) offers an automated machine learning platform specifically designed for biomedical and life science data. The product portfolio consists of two main offerings: the JADBio GUI, a no-code AutoML platform for non-expert users to perform predictive modeling and biomarker discovery through a web interface, and the JADBio API, a REST API that provides programmatic access to the same AutoML capabilities for developers integrating ML into their applications. The platform is purpose-built for multi-omics data including Genomics, Transcriptome, Metagenome, Proteome, Metabolome, and Clinical Data, and specializes in low-sample, high-dimensional datasets typical in biomedical research.

Differentiator

Problem solved

Functional benefit

Products and services

  • JADBio GUI A no-code AutoML platform that enables life scientists and bioinformaticians to perform automated machine learning analysis on biomedical and multi-omics data without programming expertise. Provides point-and-click access to predictive modeling, feature selection, biomarker discovery, and survival analysis. Targeted at academic and industry researchers who need ML capabilities without dedicated data science staff.
  • JADBio API REST API providing programmatic access to JADBio's AutoML platform, enabling developers and data scientists to integrate automated machine learning, feature selection, predictive modeling, and survival analysis into their own applications and workflows. Designed for low-sample, high-dimensional biomedical datasets including multi-omics data.

Quantifiable outcome

  • Up to 4000x reduction in biomarkers to consider without drop in predictive quality against state-of-the-art
  • +3 more outcomes

Companies that use JADBio

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

JADBio technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

JADBio partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Black Arrow BiotechcoreStrategic or Co-development Partner · 17 June 2025Black Arrow Biotech is integrating JADBio's advanced AI technology into its proprietary peptide screening platform to accelerate peptide drug discovery. This partnership combines Black Arrow's screening capabilities with JADBio's AutoML for enhanced discovery workflows.
  • DiamiR BiosciencescoreStrategic or Co-development Partner · 5 July 2023DiamiR Biosciences partnered with JADBio to utilize machine learning in assay development. DiamiR develops innovative diagnostic solutions for neurological disorders and is leveraging JADBio's AutoML platform for enhanced assay development capabilities.
  • QIAGENminorChannel Partner/ Reseller/ DistributorQIAGEN partners with JADBio for event presence and distribution. JADBio appears at QIAGEN's booth at industry conferences such as BioData World Congress for networking and lead generation.
  • FilgenminorChannel Partner/ Reseller/ DistributorFilgen is a Japanese biotechnology company and partner for distribution and research collaboration in the Japanese market.
  • Amazon Web Services (AWS)coreTechnology or IntegrationJADBio's AutoML platform is available in the AWS Marketplace, enabling cloud-based access and procurement through AWS. The partnership leverages AWS infrastructure for platform delivery.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

JADBio competitors and assessment

Company assessment

Broad incumbents

  • DataRobot: Enterprise AutoML platform serving multiple verticals including life sciences. Directly comparable on AutoML core capability but broader and general-purpose, lacking JADBio's deep multi-omics specialization.
  • H2O.ai: General-purpose AutoML and MLOps platform with some healthcare/life sciences customers. Comparable as an AutoML alternative but does not match JADBio's purpose-built biomedical feature selection.
  • Google Vertex AI: Hyperscaler AutoML offering with broad enterprise reach. Competes for the same AutoML-for-biomedical workloads from a general-purpose cloud platform angle, with vastly greater scale.
  • Schrödinger: Computational drug discovery platform combining physics-based modeling with ML. Comparable as a software-and-AI vendor to life sciences R&D, though anchored in molecular simulation rather than biomarker AutoML.

Direct peers

  • Insitro: AI-driven drug discovery company combining ML with proprietary data and wet-lab experimentation. Comparable in applying ML to life sciences, though vertically integrated into drug programs rather than selling the ML tool itself.
  • Owkin: AI-for-biopharma platform focused on multi-modal biomedical data and federated learning for drug discovery and diagnostics. Directly comparable on multi-omics/clinical data ML for life sciences.
  • CytoReason: AI platform for cell-level disease modeling and multi-omics data in drug discovery. Comparable as a domain-specialized ML platform serving biopharma R&D customers with multi-omics inputs.

Emerging players

  • Dotmatics: Scientific R&D informatics platform for life sciences with ML-augmented analysis. Comparable as a software layer for biomedical researchers, though broader in scope (ELN, LIMS, analytics).
  • Benchling: Cloud platform for life sciences R&D with growing ML/biologics capabilities. Comparable as a research informatics platform serving biologists, with overlapping buyers though different primary use cases.
  • Elucidata: Multi-omics data platform with ML-ready pipelines for biomedical researchers. Comparable as an existing partner and as an adjacent platform serving the same multi-omics + biomarker discovery workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

JADBio social profiles

Digital presence

JADBio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JADBio leadership team

Management profile

Number of profiles

Profiles5 records

JADBio funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JADBio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JADBio

What does JADBio do?

JADBio provides an automated machine learning (AutoML) platform purpose-built for low-sample, high-dimensional biomedical and life-science data. The platform automates the full ML pipeline—data preprocessing, feature selection, hyperparameter tuning, and model selection—to enable biomarker discovery, survival analysis, and predictive modeling on multi-omics data (genomics, transcriptomics, proteomics, metabolomics, clinical data and images). It is delivered via a no-code GUI for life scientists and a REST API for developers, with availability through AWS Marketplace.

Is JADBio a public or private company?

JADBio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was JADBio founded?

JADBio was founded in 2013. It employs 1 to 10 people.

Where is JADBio based?

JADBio is headquartered in Los Angeles, United States, in the North America region.

How does JADBio make money?

One revenue line is on record: saaS Subscription (AutoML Platform).

Who are JADBio's main competitors?

Broad incumbents on record are DataRobot, H2O.ai, Google Vertex AI and Schrödinger. Direct peers are Insitro, Owkin and CytoReason. Emerging players are Dotmatics, Benchling and Elucidata.

Does JADBio have an API?

Yes. JADBio AutoML REST API that provides programmatic access to the AutoML platform, enabling developers to build and automate predictive models, feature selection, and survival analysis directly from their applications. The platform is specifically designed for low-sample, high-dimensional biomedical datasets including multi-omics data. Developer documentation is at support.jadbio.com.

What industry is JADBio in?

JADBio's product category is Biomedical Analytics Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 541511 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
JadbioJADBio AutoML Case StudiesThe article serves as a promotional landing page for JADBio, highlighting its AutoML capabilities through various case studies in healthcare and biology. It lists specific research applications, including biomarker discovery for type 2 diabetes, suicide risk assessment, and cancer subtype identification. The content also includes standard website boilerplate regarding cookie consent.B2B SaaS BlogJADBio AutoML Revenue 2025: $1.2M ARR, $3.6M ValuationJADBio AutoML disclosed its current valuation at $3.6 million alongside $1.2 million in annual recurring revenue. The AI and machine learning operationalization (MLOps) software company has been bootstrapped since its founding in 2013 and has never raised venture capital or outside funding to build its SaaS business.PR NewswireDiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay DevelopmentDiamiR Biosciences announced a partnership with JADBio to use its Automated Machine Learning platform for developing predictive models from its microRNA panels. The models aim to assess risk for Alzheimer's disease and Rett syndrome. The collaboration seeks to validate DiamiR's diagnostic tests.CustomerthinkWhat is AutoML, and how can it be applied in Life Sciences?AutoML automates machine learning model development, enabling life scientists without coding expertise to build predictive models. It reduces model creation time from months to weeks and is applied in healthcare and biomedical data analysis. The article notes AutoML will not replace data researchers but frees them to focus on interpretation.HackerNoonEnabling Scientific Research and Analyses Through Automated ML | HackerNoonJADBio, founded by Ioannis Tsamardinos, offers an automated machine learning platform for biomedical data, enabling non-coders to build predictive models. The company reports over 37 scientific papers using its tools and plans interoperability with partners like QIAGEN and Indivumed.TowardsdatascienceDo we really need feature selection in a data analysis pipeline?The author argues that feature selection is necessary in data analysis pipelines, citing advantages like faster training and cost optimization. Disadvantages include the problem being NP-hard and methods often returning a single solution when multiple exist. The author recommends testing both with and without feature selection.ReadWriteThe Hitchhiker’s Guide to Survival AnalysisSurvival analysis, also called time-to-event analysis, models the time until an event occurs, such as a patient's death or a product's failure. It is applied across engineering, medicine, finance, and social sciences, with JADBio offering machine learning algorithms for high-dimensional survival data.EIN PresswireJADBio AutoML Awarded 1st Prize for Spin-off of the Year, 2021JADBio AutoML won the 1st prize for spin-off of the year in 2021, according to CEO Ioannis Tsamardinos. The company's platform lets life-scientists build machine learning models without coding, and has been used to discover new knowledge about coronavirus and cancer.How to Learn Machine LearningWhat is AutoML in Machine Learning? 🍅 How to Learn Machine LearningAutoML automates parts of the machine learning pipeline, including preprocessing, model selection, and hyperparameter tuning, while users still define targets and evaluation metrics. Platforms like auto-sklearn and AutoGluon offer no-code or Python interfaces, and the technology is expected to boost productivity without replacing data scientists.JadbioIs AutoML the future of Machine Learning?In an interview with DataTech and MarTech, JADBio CEO and co-founder Professor Ioannis Tsamardinos argues that AutoML will replace hand-coded machine learning pipelines, with future data analysts customizing AutoML tools instead. He says AutoML boosts analysis productivity, connects life scientists directly to data insights, and reduces methodological errors. JADBio's platform targets biomedicine and multi-omics, handling small- and high-dimensional datasets.